Author:
Mowry Ellen M.,Azevedo Christina J.,McCulloch Charles E.,Okuda Darin T.,Lincoln Robin R.,Waubant Emmanuelle,Hauser Stephen L.,Pelletier Daniel
Abstract
ObjectiveTo determine whether body mass index (BMI) or vitamin D status is associated with MRI measures of neurodegeneration in a cohort of individuals with relapsing-remitting multiple sclerosis (RRMS) or clinically isolated syndrome (CIS).MethodsExpression, Proteomics, Imaging, Clinical (EPIC) is a longitudinal multiple sclerosis (MS) cohort study at the University of California, San Francisco. Participants had clinical evaluations, brain MRI, and blood draws annually. We evaluated patients with CIS or RRMS at baseline. In multivariate repeated-measures analyses adjusted for age, sex, ethnicity, smoking status, and use of MS treatments, annual 25-hydroxyvitamin D levels and BMI were evaluated for their association with subsequent brain volumes (normalized gray matter [nGMV], brain parenchymal [nBPV], and white matter volumes, as determined by Structural Image Evaluation using Normalization of Atrophy-X).ResultsAmong 469 participants, each 1-kg/m2 higher BMI was independently associated with reduced nGMV in multivariate models (−1.1 mL, 95% confidence interval [CI] −1.8 to −0.5, p = 0.001). BMI was likewise independently associated with nBPV (nBPV per 1-kg/m2 greater BMI: −1.1 mL, 95% CI −2.1 to −0.05, p = 0.039). Vitamin D levels did not appear to be meaningfully associated with brain volumes.ConclusionsHigher BMI appears to be associated with greater reductions in nGMV and nBPV, which is relevant because, in particular, nGMV loss portends greater longer-term disability. Because obesity is modifiable, further studies should explore these relationships in detail, and evaluating the effect of reducing BMI on imaging and clinical outcomes in MS may be warranted.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献